What is Benicar?
Benicar is the brand name for the prescription drug olmesartan, a medication used to reduce blood pressure and hypertension (chronic high blood pressure). Olmesartan is also contained in the drugs sold under the names of Benicar HCT, Tribenzor and Azor. Benicar is made by the Japanese company Daiichi Sankyo and co-promoted in the U.S. by Forest Laboratories.
Has Benicar Been Widely Prescribed?
Yes. According to the U.S. Food and Drug Administration, over ten million Benicar prescriptions were made to approximately two million patients in the U.S. in 2012. The U.S. Food and Drug Administration has warned that patients with high blood pressure taking Benicar could suffer from serious side effects, including chronic diarrhea, unusual weight loss, and severe gastrointestinal problems.
Benicar Dangers and Potential Side Effects
Patients taking Benicar under the recommended dosage have experienced major complications, including:
- severe, chronic diarrhea with substantial weight loss
- sprue-like enteropathy
- villous atrophy
- lymphocytic, collagenous and/or microscopic colitis
Sprue-like enteropathy and villous atrophy are both conditions involving destruction of the intestinal lining that are characterized by severe, chronic diarrhea, malabsorption, and substantial weight loss. These conditions often result in repeat hospitalizations, and in some cases cause secondary complications such as renal failure. The conditions can develop months to years after starting Benicar use. Patients with Benicar-induced gastrointestinal problems are often misdiagnosed with celiac disease.
Has Benicar Been Recalled?
No. However, in July 2013, the FDA required the addition of warnings regarding the risk of sprue-like enteropathy and villous atrophy to the drug labels of Benicar, Benicar HCT, Tribenzor and Azor.
Scovern Law represents patients prescribed Benicar who have experienced chronic diarrhea with substantial weight loss, severe gastrointestinal problems, and the life-threatening conditions of sprue-like enteropathy and villous atrophy in litigation against Japan-based Daiichi Sankyo, Benicar’s manufacturer, and Forest Laboratories, which marketed Benicar in the U.S. The complaints allege that Benicar was insufficiently tested and not accompanied by adequate instructions and warnings to apprise consumers of the full risks and side effects associated with its use.
Contact Scovern Law
If you or a family member have suffered serious complications after being prescribed Benicar, Benicar HCT, Tribenzor or Azor, you may be eligible to file a claim. For a free and prompt evaluation of your case, with no obligation on your part, please contact a Benicar lawyer at Scovern Law at 1.888.725.1890.